Explore

Trendline Trendline
Sanofi Halts Atopic Dermatitis Trials for Kymab Acquisition Due to Efficacy Concerns

Sanofi Halts Atopic Dermatitis Trials for Kymab Acquisition Due to Efficacy Concerns

Sanofi Halts Atopic Dermatitis Trials for Kymab Acquisition Due to Efficacy Concerns
Trendline Trendline
Roche's CEO Confident in Growth with Robust Late-Stage Pipeline

Roche's CEO Confident in Growth with Robust Late-Stage Pipeline

Roche's CEO Confident in Growth with Robust Late-Stage Pipeline
Trendline Trendline
Trialbee Appoints Michael Meerovich as CFO to Drive Global Growth Strategy

Trialbee Appoints Michael Meerovich as CFO to Drive Global Growth Strategy

Trialbee Appoints Michael Meerovich as CFO to Drive Global Growth Strategy
Trendline Trendline
Roche Discontinues Carmot Obesity Drug, Focuses on Promising Candidate

Roche Discontinues Carmot Obesity Drug, Focuses on Promising Candidate

Roche Discontinues Carmot Obesity Drug, Focuses on Promising Candidate
Trendline Trendline
FDA Advances AI in Clinical Trial Design to Enhance Drug Development

FDA Advances AI in Clinical Trial Design to Enhance Drug Development

FDA Advances AI in Clinical Trial Design to Enhance Drug Development
Trendline Trendline
Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth Phase

Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth Phase

Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth Phase
Trendline Trendline
Arrowhead Pharmaceuticals Reports Positive Phase 3 Data for Triglyceride-Lowering Drug, Challenging Ionis

Arrowhead Pharmaceuticals Reports Positive Phase 3 Data for Triglyceride-Lowering Drug, Challenging Ionis

Arrowhead Pharmaceuticals Reports Positive Phase 3 Data for Triglyceride-Lowering Drug, Challenging Ionis
Trendline Trendline
Challenges in Drug Discovery Highlight Need for Human-Centric Preclinical Models

Challenges in Drug Discovery Highlight Need for Human-Centric Preclinical Models

Challenges in Drug Discovery Highlight Need for Human-Centric Preclinical Models
Trendline Trendline
Agios Pharmaceuticals Discontinues Sickle Cell Drug Candidate After Failing to Outperform Competitors

Agios Pharmaceuticals Discontinues Sickle Cell Drug Candidate After Failing to Outperform Competitors

Agios Pharmaceuticals Discontinues Sickle Cell Drug Candidate After Failing to Outperform Competitors
Trendline Trendline
Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth

Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth

Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth
Trendline Trendline
Repligen Acquires BioLife Solutions in $1.5 Billion Deal to Boost Cell Therapy Market Presence

Repligen Acquires BioLife Solutions in $1.5 Billion Deal to Boost Cell Therapy Market Presence

Repligen Acquires BioLife Solutions in $1.5 Billion Deal to Boost Cell Therapy Market Presence
Trendline Trendline
Atossa Therapeutics Presents (Z)-Endoxifen Data for McCune-Albright Syndrome

Atossa Therapeutics Presents (Z)-Endoxifen Data for McCune-Albright Syndrome

Atossa Therapeutics Presents (Z)-Endoxifen Data for McCune-Albright Syndrome